Trial Profile
Elvitegravir concentrations in seminal plasma in HIV-1 infected patients (ELVIs Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2015
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms ELVIs
- 10 Oct 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 15 Apr 2014 New trial record